Hennig, Stefanie <br/><br/>
Safety of inhaled (Tobi®) and intravenous tobramycin in young children with cystic fibrosis.  [electronic resource] 

 -  Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society  Jul 2014 
 - 428-34 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-5010 
<br/><br/><label>Standard No.: </label>10.1016/j.jcf.2014.01.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Administration, Intravenous<br/>Anti-Bacterial Agents--administration & dosage<br/>Child, Preschool<br/>Cystic Fibrosis--complications<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Male<br/>Pseudomonas Infections--complications<br/>Pseudomonas aeruginosa--isolation & purification<br/>Retrospective Studies<br/>Tobramycin--administration & dosage<br/>Treatment Outcome